Work

Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines: Perceptions and Attitudes From the Food and Drug Administration Public Commentary

Year: 2022

Type: article

Abstract: Authorization of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines for children has ushered in a new phase of the immunization campaign to address the pandemic but has been received with mixed responses from parents, children, and opinion leaders. Herein we consider perceptions and attitudes towards pediatric SARS-CoV-2 vaccines from a Food and Drug Administration (FDA) public commentary reflecting more than 63 000 comments.

Source: Clinical Infectious Diseases

DOI: 10.1093/cid/ciac343

Authors: Elissa R Weitzman, Amy C Sherman, Ofer Levy

Institutions: Boston Children's Hospital, Harvard University, Brigham and Women's Hospital, Broad Institute, Massachusetts Institute of Technology

Language: English

Topic: Vaccine Coverage and Hesitancy

Subfield: Health

Field: Social Sciences

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,320